Muscle Biopsy Findings in Combination With Myositis-Specific Autoantibodies Aid Prediction of Outcomes in Juvenile Dermatomyositis.

In contrast to those with anti–Mi‐2, patients with anti‐MDA5 antibodies displayed a nonsignificant trend toward higher odds of remaining on treatment over time, despite having less severe muscle disease at the time of biopsy.

also in 5,406 other papers